Abstract
The aryl hydrocarbon receptor (AhR) has a fundamental role during postnatal liver development and is essential for mediating dioxin toxicity. However, the genetic programs mediating, both, the toxic and physiological effects downstream of the transcription factor AhR are in major parts unknown. We have identified the proto-oncogene c-jun as a novel target gene of AhR. Induction of c-jun depends on activation of p38–mitogen-activated protein kinase (MAPK) by an AhR-dependent mechanism. None of the kinases that are known to phosphorylate p38-MAPK is activated by AhR. Neither the dephosphorylation rate of p38–MAPK is reduced. Furthermore, increased p38–MAPK phosphorylation in response to dioxins does not require ongoing transcription. These findings establish activating ‘cross-talk’ with MAPK signaling as a novel principle of AhR action, which is apparently independent of the AhR's function as a DNA-binding transcriptional activator.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bender K, Göttlicher M, Whiteside S, Rahmsdorf HJ and Herrlich P . (1998). EMBO J., 17, 5170–5181.
Burbach KM, Poland A and Bradfield CA . (1992). Proc. Natl. Acad. Sci. USA, 89, 8185–8189.
Cavigelli M, Li WW, Lin A, Su B, Yoshioka K and Karin M . (1996). EMBO J., 15, 6269–6279.
Chang L and Karin M . (2001). Nature, 410, 37–40.
Couture L, Abbott B and Birnbaum L . (1990). Teratology, 42, 619–627.
De Bosscher K, Vanden Berghe W and Haegeman G . (2003). Endocr. Rev., 24, 488–522.
Dunlap JC . (1998). Curr. Opin. Genet. Dev., 8, 400–406.
Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y and Fujii-Kuriyama Y . (1992). Biochem. Biophys. Res. Commun., 184, 246–253.
Enan E and Matsumura F . (1995). Biochem. Pharmacol., 49, 249–261.
Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM and Gonzalez FJ . (1995). Science, 268, 722–726.
Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM and Gonzalez FJ . (1996). Toxicol. Appl. Pharmacol., 140, 173–179.
Ge B, Gram H, Di Padova F, Huang B, New L, Ulevitch RJ, Luo Y and Han J . (2002). Science, 295, 1291–1294.
Herrlich P . (2001). Oncogene, 20, 2465–2475.
Hoffer A, Chang CY and Puga A . (1996). Toxicol. Appl. Pharmacol., 141, 238–247.
Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA and Hankinson O . (1991). Science, 252, 954–958.
Huff J, Lucier G and Tritscher A . (1994). Annu. Rev. Pharmacol. Toxicol., 34, 343–372.
Jochum W, Passegue E and Wagner EF . (2001). Oncogene, 20, 2401–2412.
Knebel A, Rahmsdorf HJ, Ullrich A and Herrlich P . (1996). EMBO J., 15, 5314–5325.
Kolluri SK, Weiss C, Koff A and Göttlicher M . (1999). Genes Dev., 13, 1742–1753.
Leppä S and Bohmann D . (1999). Oncogene, 18, 6158–6162.
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans R . (1995). Cell, 83, 835–839.
Marinissen MJ, Chiariello M and Gutkind JS . (2001). Genes Dev., 15, 535–553.
Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY, Laine J, Sakai T, Korsmeyer SJ, Casper RF, Sherr DH and Tilly JL . (2001). Nat. Genet., 28, 355–360.
McLachlan JA . (2001). Endocr. Rev., 22, 319–341.
Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E and Auricchio F . (1996). EMBO J., 15, 1292–1300.
Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M and Auricchio F . (1998). EMBO J., 17, 2008–2018.
Nebert DW . (1994). Biochem. Pharmacol., 47, 25–37.
Nebert DW, Puga A and Vasiliou V . (1993). Ann. NY. Acad. Sci., 685, 624–640.
Noselli S and Perrimon N . (2000). Science, 290, 68–69.
Ogawa S, Lozach J, Jepsen K, Sawka-Verhelle D, Perissi V, Sasik R, Rose DW, Johnson RS, Rosenfeld MG and Glass CK . (2004). Proc. Natl. Acad. Sci. USA, 101, 14461–14466.
Peterson RE, Theobald HM and Kimmel GL . (1993). Crit. Rev. Toxicol., 23, 283–335.
Puga A, Nebert DW and Carrier F . (1992). DNA Cell Biol., 11, 269–281.
Reyes H, Reisz-Porszasz S and Hankinson O . (1992). Science, 256, 1193–1195.
Schmidt JV and Bradfield CA . (1996). Ann. Rev. Cell. Dev. Biol., 12, 55–89.
Suskind RR . (1985). Scand. J. Work Environ. Health, 11, 165–171.
Swanson HI and Bradfield CA . (1993). Pharmacogenetics, 3, 213–230.
van Dam H and Castellazzi M . (2001). Oncogene, 20, 2453–2464.
Vanden Heuvel JP and Lucier G . (1993). Environ. Health Perspect., 100, 189–200.
Vogt PK . (2001). Oncogene, 20, 2365–2377.
Wada T and Penninger JM . (2004). Oncogene, 23, 2838–2849.
Weiss C and Bohmann D . (2004). Cell Cycle, 3, 111–113.
Weiss C, Kolluri SK, Kiefer F and Göttlicher M . (1996). Exp. Cell Res., 226, 154–163.
Weiss C, Schneider S, Wagner EF, Zhang X, Seto E and Bohmann D . (2003). EMBO J., 22, 3686–3695.
Werling U, Siehler S, Litfin M, Nau H and Göttlicher M . (2001). Mol. Pharmacol., 59, 1269–1276.
Zugerman C . (1990). Dermatol. Clin., 8, 209–213.
Acknowledgements
We thank Dirk Bohmann and Catherine Ovitt for critical reading of the manuscript and Elke Martin for technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Weiss, C., Faust, D., Dürk, H. et al. TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38–MAPK-dependent pathway. Oncogene 24, 4975–4983 (2005). https://doi.org/10.1038/sj.onc.1208679
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208679
Keywords
This article is cited by
-
The LIM domain protein nTRIP6 modulates the dynamics of myogenic differentiation
Scientific Reports (2021)
-
The Brassica-derived phytochemical indolo[3,2-b]carbazole protects against oxidative DNA damage by aryl hydrocarbon receptor activation
Archives of Toxicology (2017)
-
Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target
Archives of Toxicology (2017)
-
The LIM domain protein nTRIP6 acts as a co-repressor for the transcription factor MEF2C in myoblasts
Scientific Reports (2016)
-
SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
BMC Cancer (2014)